Live Breaking News & Updates on Polypid ltd

Stay informed with the latest breaking news from Polypid ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Polypid ltd and stay connected to the pulse of your community

PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Ireland , Japan , Italy , Dafna , Ha-afon , Israel , Hungary , Germany , Portugal , Japanese , Jonny-missulawin , Roy-buchanan

PolyPid (NASDAQ:PYPD) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, Q3 2025 earnings […]

Rosalind-advisors-inc , Polypid-company-profile , Nasdaq , Polypid-ltd , Free-report , Get-free-report , Rosalind-advisors , Pid-ltd , Polypid-daily , Polypid , Nasdaq-pypd

PolyPid (NASDAQ:PYPD) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, […]

Polypid-ltd , Rosalind-advisors-inc , Nasdaq , Free-report , Get-free-report , Rosalind-advisors , Pid-ltd , Polypid-daily , Polypid , Nasdaq-pypd , Pypd

Analyzing Co-Diagnostics (NASDAQ:CODX) and PolyPid (NASDAQ:PYPD)

Analyzing Co-Diagnostics (NASDAQ:CODX) and PolyPid (NASDAQ:PYPD)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Israel , Utah , Salt-lake-city , Petah-tikva , News-ratings-for-co , Diagnostics-inc , Polypid-ltd , Get-free-report , Given-polypid , Pid-ltd , Co-diagnostics-daily

PolyPid (NASDAQ:PYPD) vs. LeMaitre Vascular (NASDAQ:LMAT) Head-To-Head Comparison

PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings and Valuation This table compares PolyPid and […]

Massachusetts , United-states , Burlington , Israel , Petah-tikva , Lemaitre-vascular-inc , Polypid-ltd , Lemaitre-vascular , Vascutech-inc , Get-free-report , Maitre-vascular , Given-lemaitre-vascular

Reviewing LeMaitre Vascular (NASDAQ:LMAT) & PolyPid (NASDAQ:PYPD)

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares LeMaitre Vascular […]

Burlington , Massachusetts , United-states , Israel , Petah-tikva , Lemaitre-vascular , Polypid-ltd , Vascutech-inc , Lemaitre-vascular-inc , Get-free-report , Maitre-vascular , Given-lemaitre-vascular

Financial Review: LeMaitre Vascular (NASDAQ:LMAT) versus PolyPid (NASDAQ:PYPD)

PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent […]

Burlington , Massachusetts , United-states , Israel , Petah-tikva , Polypid-ltd , Vascutech-inc , Lemaitre-vascular-inc , Lemaitre-vascular , Get-free-report , Maitre-vascular , Given-lemaitre-vascular

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024 New Preclinical Data Showed OncoPLEX Injected Intratumorally Reduced Tumor Volume and Improved Survival in New Animal Models Recent Successful $16 Million Financing Extends Company’s Cash Runway

Israel , Dafna , Ha-afon , Dikla-czaczkes-akselbrad , Brian-ritchie , Czaczkes-akselbrad , Company-annual-report-on-form , Twitter , Polypid-ltd , Linkedin , Fund-polypid , Nasdaq

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Israel , Brian-ritchie , Polypid-ltd , Twitter , Linkedin , Nasdaq , Report-fourth-quarter , Operational-highlights , Call-dial-in , Webcast-information , Polymer-lipid-encapsulation , Active-pharmaceutical-ingredients

Financial Survey: PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM)

PolyPid (NASDAQ:PYPD – Get Free Report) and Assure (NASDAQ:IONM – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings. Risk and Volatility PolyPid has a beta of 1.45, […]

Englewood , Colorado , United-states , Israel , Petah-tikva , Nasdaq , Polypid-ltd , Holdings-corp , Get-free-report , Given-assure , Pid-ltd , Polypid-daily